Article: Helix licenses new technology.(TECHNOLOGY & PACKAGING)

US peptide supplier Helix BioMedix has licensed its patent pending PiP3 technology to Rodan + Fields.

Rodan + Fields plans to use the technology and Helix's patented peptides to develop proprietary formulations for its regimen-based skin care line.

"This new technology has a broad range of potential applications in our product line and works in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!